Clinical Trial Update: Tranexamic Acid to Reduce Delirium After Gastrointestinal Surgery: the TRIGS-D Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tranexamic acid to reduce postoperative delirium after gastrointestinal surgery; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia
• Postoperative Delirium

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Bayside Health | Conditions: Surgical Site Infection, Dementia | Phase 3 | Status: ACTIVE_NOT_RECRUITING